Genocea Biosciences, Inc.
Records under this name other than patents Genocea Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Genocea Biosciences, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,570,387 | Antigen screening system Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,045,791 | Antigen screening system Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,895,436 | Vaccines Against Herpes Simplex Virus Type 2: Compositions and Methods for Eliciting an Immune Response Formerly held In force · High confidence | In force | High confidence | |
| US 10,653,771 | Vaccines Against Herpes Simplex Virus Type 2: Compositions and Methods for Eliciting an Immune Response Formerly held In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 8,617,564 | Vaccines Against Herpes Simplex Virus Type 2: Compositions and Methods for Eliciting an Immune Response Formerly held In force · High confidence | In force | High confidence | |
| US 9,782,474 | Vaccines Against Herpes Simplex Virus Type 2: Compositions and Methods for Eliciting an Immune Response Formerly held In force · High confidence | In force | High confidence | |
| US 9,624,273 | Nucleic Acid Vaccines Against Herpes Simplex Virus Type 2: Compositions and Methods for Eliciting an Immune Response Formerly held In force · High confidence | In force | High confidence | |
| US 10,350,288 | Methods and Compositions for Treating Herpes Formerly held In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 10,105,412 | Vaccines and Compositions Against Streptococcus Pneumoniae Formerly held Lapsed on the fee record Ended Oct 23, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 23, 2026 | Low confidence |
| US 9,873,870 | Antigen screening system Formerly held Lapsed on the fee record Ended Jan 23, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 23, 2026 | USPTO record |